"I think the Company has higher priorities concentrating on running a business than to spend effort trying to accommodate the irrational behaviour of retailers vulnerable to superstition."
if that is the case - then why put out anns. like this?
Lets face facts here -------- institutions are across this - they just had briefings
so - it is very clearly aimed at retailers - unless they thought that some of the audience was asleep in Hong Kong.
TA discussion, page-5134
-
- There are more pages in this discussion • 1,207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AJX (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $15.62M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $350 | 35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 131370 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 58736 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 131370 | 0.010 |
2 | 700000 | 0.009 |
3 | 516044 | 0.008 |
1 | 200000 | 0.007 |
3 | 628000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 58736 | 1 |
0.013 | 240000 | 1 |
0.014 | 564269 | 2 |
0.015 | 1200 | 1 |
0.017 | 15000 | 1 |
Last trade - 15.59pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
AJX (ASX) Chart |